Protective effects of azathioprine and phenobarbital on acute liver damage produced by galactosamine.
D000208:Acute Disease; D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D001379:Azathioprine / Q000494:pharmacology* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000201:enzymology / Q000209:etiology* / Q000517:prevention & control; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D005688:Galactosamine; D014453:Glucuronosyltransferase / Q000378:metabolism; D008099:Liver / Q000187:drug effects* / Q000201:enzymology; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology; D009247:NADH, NADPH Oxidoreductases / Q000378:metabolism; D010634:Phenobarbital / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats
D005688:Galactosamine; D003577:Cytochrome P-450 Enzyme System; D009247:NADH, NADPH Oxidoreductases; D014453:Glucuronosyltransferase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001379:Azathioprine; D010634:Phenobarbital